Summary

bloodcut8 Users

  • 177 Lu-PSMA-617 radioligand treatment regarding metastatic castration-resistant prostate cancer: Initial 254-patient comes from a potential registry (Actuality Review).
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-08-02, 21:38:58
Local Time:
2025-08-05, 14:53:44
Last Active:
2025-08-03, 00:10:22
Signature:
Emerging evidence in clinical and preclinical studies indicates that success of immunotherapies can be impacted by the state of the microbiome. Unders